In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in ...
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
Pillar Biosciences and AstraZeneca today announced an expansion of their existing laboratory access program for NGS-based ...
CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS ...
The National Organization for Rare Disorders (NORD®) has designated UC Davis Health as a NORD Rare Disease Center of ...
Morning Overview on MSN
Humanoid AI robot retires after working on 30,000+ BMW X3s
On a BMW assembly line in South Carolina, a humanoid robot has quietly reached a milestone that many human workers never see, ...
IBI3003 is a novel trispecific antibody targeting GPRC5D, BCMA and CD3 simultaneously. Its dual-targeting design against BCMA and GPRC5 aims to overcome single antigen escape in multiple myeloma (MM).
The Daily Galaxy on MSN
Meet Skhūl: A primal child buried in Israel who is possibly the first known hybrid human-Neanderthal in history
The buried remains of a small child, discovered nearly a century ago in a cave on Israel’s Mount Carmel, are once again at ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
That belief underpins our manifesto for the 2026 Scottish elections, where children and young people sit firmly at the heart ...
Clean energy targets depend on infrastructure that works, and regulation that understands your challenges. When projects grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback